The CVS Health Research Institute released a first look at the comparative utilization of two new hepatitis C treatments in the weeks following their respective launches.
The Food and Drug Administration has approved a new drug for hepatitis C made by Gilead Sciences, the drug maker said Friday.
More than two-thirds of patients with hepatitis C achieved sustained virologic response or cure after completing newer “triple therapy” treatment, according to a Walgreens Specialty Pharmacy study released Friday.
The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.
An investigational drug made by Pharmasset for treating hepatitis C will get expedited review from...